Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin

This publication has 45 references indexed in Scilit:

• Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami
  Peptides, 1989
• Cerebral Glucose Utilization in Rats is Not Altered by Hindlimb Restraint or by Femoral Artery and Vein Cannulation
  Journal of Cerebral Blood Flow & Metabolism, 1988
• Functional Correlates of Serotonin 5-HT₁Recognition Sites
  Journal of Receptor Research, 1988
• Arecoline-induced elevations of regional cerebral metabolism in the conscious rat
  Brain Research, 1985
• Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP
  Life Sciences, 1985
• Serotonin receptor changes after chronic antidepressant treatments: Ligand binding, electrophysiological, and behavioral studies
  Life Sciences, 1983
• Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine
  Life Sciences, 1983
• Demonstration of aromatic l-amino acid decarboxylase activity in human brain with l-dopa and l-5-hydroxytryptophan as substrates by high-performance liquid chromatography with electrochemical detection
  Neurochemistry International, 1981
• THE [¹⁴C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT¹
  Journal of Neurochemistry, 1977
• The Distribution of Adrenergic Nerve Fibres to the Blood Vessels in Skeletal Muscle
  Acta Physiologica Scandinavica, 1965